middle.news
Patrys Secures A$3.2 Million to Propel Injectable Quetiapine Trials
9:54am on Monday 20th of April, 2026 AEST
•
Healthcare
Read Story
Patrys Secures A$3.2 Million to Propel Injectable Quetiapine Trials
9:54am on Monday 20th of April, 2026 AEST
Key Points
Placement raised approximately A$3.2 million at A$0.024 per share
Funds earmarked for Phase 1A clinical trial and manufacturing readiness
Directors to participate subject to shareholder approval
Placement includes attaching unlisted options exercisable at A$0.048
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Patrys (ASX:PAB)
OPEN ARTICLE